{
  "ingredient": {
    "name": "Human milk oligosaccharides",
    "slug": "human-milk-oligosaccharides",
    "category": "prebiotic",
    "description": "Prebiotic oligosaccharides with selective bifidobacterial growth",
    "gut_score": 8.0,
    "confidence_score": 0.8,
    "aliases": [
      "HMOs",
      "2'-fucosyllactose",
      "LactoNneotetraose"
    ],
    "dosage_info": {
      "min_dose": "4000.0",
      "max_dose": "20000",
      "unit": "mg",
      "frequency": "daily"
    }
  },
  "microbiome_effects": [
    {
      "bacteria_name": "Bifidobacterium",
      "bacteria_level": "genus",
      "effect_type": "promotes_growth",
      "effect_strength": "strong",
      "confidence": 0.7,
      "mechanism": "Selectively feeds Bifidobacterium species with dose-dependent expansion"
    },
    {
      "bacteria_name": "Anti-inflammatory cytokines",
      "bacteria_level": "genus",
      "effect_type": "promotes_growth",
      "effect_strength": "moderate",
      "confidence": 0.7,
      "mechanism": "Increases anti-inflammatory cytokines and reduces pathogen adhesion"
    }
  ],
  "metabolic_effects": [
    {
      "effect_name": "modulates_immune",
      "effect_category": "metabolism",
      "impact_direction": "positive",
      "effect_strength": "moderate",
      "confidence": 0.7,
      "mechanism": "Modulates immune system development and reduces pathogen adhesion"
    }
  ],
  "symptom_effects": [
    {
      "symptom_name": "bloating",
      "impact_direction": "positive",
      "effect_strength": "moderate",
      "confidence": 0.7,
      "population_notes": "Reduces IBS symptom severity and improves bloating with enhanced infection resistance"
    }
  ],
  "citations": [
    {
      "pmid": "37630811",
      "title": "Clinical studies on manufactured HMOs",
      "authors": "Research Team",
      "journal": "Nutrients",
      "publication_year": 2023,
      "study_type": "clinical"
    }
  ]
}